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Introduction
Sphingolipids are vital components of cellular membranes in 
organisms ranging from mammals to yeast. Besides providing a 
structural framework for plasma membrane (PM) organization, 
sphingolipids are dynamic regulators of a wide range of cellular 
processes. Sphingoid long-chain bases (LCBs), ceramides, and 
other intermediates of sphingolipid metabolism act as signaling 
molecules in the regulation of cell growth, death, migration, and 
membrane trafficking (Spiegel and Milstien, 2003; Hannun and 
Obeid, 2008). Notably, a sensitive balance between phosphory-
lated LCBs and ceramides, referred to as the LCBP/ceramide 
rheostat, appears critical for normal cell growth and lifespan 
(Mandala et al., 1998; Kobayashi and Nagiec, 2003). Moreover, 
sphingolipids form gradients along the secretory pathway that 
may affect protein sorting through hydrophobic matching of 
membrane spans (Bretscher and Munro, 1993; Holthuis et al., 
2001; Patterson et al., 2008).
Given their impact on cell organization and survival, the 
local concentration of sphingolipids and their metabolic inter-
mediates must be tightly controlled. Although the mechanisms 
that regulate membrane sterol concentrations are well established 
(Goldstein et al., 2006), little is known about the mechanisms 
controlling sphingolipid homeostasis. As ceramides constitute 
the backbone of all sphingolipids and directly participate in cel-
lular life and death decisions (Morales et al., 2007), controlling 
their local concentration is critical. Ceramides can be generated 
by the breakdown of sphingomyelin (SM) through SMases   
at the PM (Andrieu-Abadie and Levade, 2002) or synthesized 
de novo by N-acylation of LCBs on the cytosolic surface of the 
ER (Mandon et al., 1992; Hirschberg et al., 1993). The latter 
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of an SMS1-related (SMSr) enzyme, which catalyses 
the synthesis of the SM analogue ceramide phospho-
ethanolamine (CPE) in the ER lumen. Strikingly, SMSr 
produces only trace amounts of CPE, i.e., 300-fold less 
than SMS1-derived SM. Nevertheless, blocking its cat-
alytic activity causes a substantial rise in ER ceramide 
levels and a structural collapse of the early secretory 
pathway. We find that the latter phenotype is not caused 
by depletion of CPE but rather a consequence of cer-
amide  accumulation  in  the  ER.  Our  results  establish 
SMSr as a key regulator of ceramide homeostasis that 
seems to operate as a sensor rather than a converter of 
ceramides in the ER.
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mixtures showed the presence of an NBD-labeled product with a 
retention factor value distinct from that of NBD–ceramide phos-
phoinositol and NBD-SM. The product was missing in reactions 
performed with control (empty vector) cells (Fig. 1 C). Liquid chro-
matography (LC) mass spectrometry (MS)/MS analysis identified 
the product as NBD-CPE (unpublished data), suggesting that 
SMSr proteins can synthesize CPE.
To determine whether SMSr proteins recognize natural 
ceramides as substrates for CPE production, a yeast strain was 
used in which the endogenous enzymes for ceramide production 
were replaced by mouse ceramide synthase CerS5 (Cerantola   
et al., 2007). As the ceramides produced in this strain structur-
ally resemble those found in animal cells, they were expected to 
be suitable substrates for CPE biosynthesis. LC/MS/MS analy-
ses revealed the presence of several molecular species of CPE 
in lipid extracts of both hSMSr- and dSMSr-expressing strains 
(Fig. 1 D). The extracts were devoid of SM. No CPE was detect-
able in control cells. Together, these results demonstrate that 
SMSr proteins function as CPESs.
SMSr represents a major CPES activity in 
mammalian cells
To investigate whether SMSr corresponds to the CPES activity 
previously described in mammalian cells (Malgat et al., 1986, 
1987), lysates of HeLa cells in which hSMSr was overexpressed 
or depleted by RNAi were analyzed for CPES activity. Incubation 
of control cell lysates with NBD-Cer yielded three fluorescent 
products, corresponding to NBD-glucosylceramide (GlcCer), 
NBD-SM, and NBD-CPE (Fig. 2 A, left lane). Although forma-
tion of NBD-CPE was stimulated by addition of PE, addition of 
either PC or CDP-ethanolamine had no effect, suggesting that PE 
is the headgroup donor in the CPES reaction (Fig. 2 B; Fig. S1; 
and see Fig. 4 E). Heterologous expression of V5-tagged hSMSr 
led to a sixfold increase in CPES activity, leaving SMS activity 
unaffected (Fig. 2, A and C). Conversely, CPES activity dropped 
>50% after depletion of hSMSr by RNAi (Fig. 2 D). This shows 
that hSMSr represents a major CPES activity in HeLa cells.
To determine the contribution of SMSr to CPE biosynthesis 
in vivo, endogenous CPE production levels were monitored by 
metabolic labeling of various cell lines. Labeling human colon car-
cinoma Caco-2, liver carcinoma Hep-G2, or HeLa cells for 48 h 
with [
14C]ethanolamine yielded only trace amounts of radiolabeled 
CPE (Fig. 2 F). The same was true when HeLa or CHO-K1 cells 
were labeled with [
3H]sphingosine (Fig. 2 G). In contrast, labeling 
Drosophila S2 cells with [
14C]ethanolamine showed that the CPE 
production level in these cells is much higher (Fig. 2 F, right). 
Indeed, MS analyses revealed that although S2 cells contain a sub-
stantial amount of CPE (15.3 ± 1.1 mol% of total phospholipid;   
n = 3), the CPE levels in HeLa or CHO-K1 cells are exceedingly 
low (0.03 mol%, i.e., 300-fold lower than SM; see Fig. 5 A).
SMSr produces only trace amounts of CPE
Although mammalian cells contain a readily detectable CPES 
activity (Fig. 2 A), their CPE content is very low. One explana-
tion for this discrepancy could be that SMSr resides in a com-
partment  that  is  not  easily  reached  by  newly  synthesized 
ceramide. To test this, the subcellular distribution of hSMSr-V5 
reaction is controlled by components of TORC2 (target of rapa-
mycin complex 2) presumably through phosphorylation of the 
ceramide synthase (Aronova et al., 2008).
In mammalian cells, the bulk of newly synthesized ce-
ramides is converted to SM in the lumen of the Golgi (Tafesse 
et al., 2006). Efficient delivery of ER-derived ceramides to the 
site of SM production requires a cytosolic ceramide transfer 
protein (CERT; Hanada et al., 2003). Besides a START domain 
that binds ceramide, CERT contains an FFAT motif for inter-
action with the ER membrane and a pleckstrin homology domain 
targeting the Golgi. CERT is phosphorylated at a serine repeat 
motif, which down-regulates its ceramide transport function. 
Loss of SM and cholesterol from cells causes dephosphoryla-
tion of the motif, resulting in CERT activation (Kumagai et al., 
2007). Thus, the local concentration of ceramides in cells is 
controlled by an intricate network of lipid-metabolizing enzymes, 
transfer proteins, kinases, and phosphatases.
SM production is mediated by a phosphatidylcholine (PC)/
ceramide cholinephosphotransferase or SM synthase (SMS). 
Mammalian cells contain two SMS isoforms, SMS1 in the Golgi 
and SMS2 at the PM (Huitema et al., 2004). In addition, the mam-
malian genome encodes a third SMS-related (SMSr) protein of 
unknown function with homologues in nematodes and insects like 
Drosophila melanogaster (Fig. 1 A). Drosophila does not synthe-
size SM but produces the SM analogue ceramide phosphoethanol-
amine (CPE) as a major membrane constituent (Rao et al., 2007). 
CPE production also occurs in mammals and is catalyzed by a 
phosphatidylethanolamine (PE)/ceramide ethanolamine phos-
photransferase or CPE synthase (CPES; Malgat et al., 1986, 1987). 
The identity of the responsible enzyme is not known. Production 
of SM and CPE involves a similar reaction chemistry (Malgat   
et al., 1986). Because SMS1, SMS2, and SMSr are structurally re-
lated and share two highly conserved sequence motifs with puta-
tive active site residues (Fig. 1 B; Huitema et al., 2004; Tafesse   
et al., 2006), SMSr is a prime candidate for the elusive CPES.
In this study, we show that SMSr displays CPES activity 
and, contrary to SMS1 and 2, localizes to the ER. However, we 
find that SMSr produces only trace amounts of CPE and that 
bulk production of CPE in insect cells is mediated by a different 
enzyme. Unexpectedly, blocking SMSr activity causes a marked 
increase of ceramide levels in the ER. This is accompanied by a 
fragmentation of ER exit sites and a structural collapse of the 
Golgi. These morphological aberrations are not caused by a 
lack of CPE but rather a consequence of the ceramide accumu-
lation in the ER. We propose that SMSr is a CPES with dual 
activity as ceramide sensor to control ceramide homeostasis in 
the ER and that the latter process is critical for the integrity of 
the early secretory pathway.
Results
SMSr proteins display CPES activity
To test whether SMSr proteins catalyze CPE production, human 
SMSr (hSMSr) and Drosophila SMSr (dSMSr) were expressed 
in budding yeast, an organism lacking endogenous CPES activity. 
SMSr-expressing cells were lysed and incubated with fluores-
cent C6-NBD–ceramide (NBD-Cer). TLC analysis of the reaction 1015 SMSr CONTROLS CERAMIDE HOMEOSTASIS IN THE ER • Vacaru et al.
3H-CPE, indicating that the low CPE content of mammalian cells 
is unlikely caused by scavenging of ceramides from the site of 
CPE production.
Another explanation for the low CPE content could be the 
presence of an inhibitory factor or environment in the ER. 
We found that removal of the N-terminal sterile  motif (SAM) 
domain of hSMSr caused its redistribution from the ER to the 
Golgi (Fig. 2 E and Fig. S2 B) but did not affect its enzymatic 
activity (see Fig. 4 A). However, metabolic labeling of HeLa 
cells expressing hSMSrSAM showed no significant increase 
in CPE production levels compared with cells expressing the 
full-length protein (Fig. 2 F). Thus, the ER does not seem to 
impose an inhibitory environment on SMSr enzymatic activity.
Last, we investigated whether CPE is readily converted to 
another product. Although SM production in mammalian cells 
mainly occurs through SMS1-mediated headgroup transfer 
from PC to ceramide (Tafesse et al., 2006), an alternative path-
way involves methylation of CPE (Muehlenberg et al., 1972). 
To investigate the relative contribution of the latter pathway 
was analyzed in HeLa cells by immunofluorescence microscopy. 
hSMSr-V5 gave a reticular and nuclear envelope staining pattern 
and colocalized with the ER marker protein disulfide isomerase 
(Fig. 2 E and Fig. S2 A). The ER localization of hSMSr does not 
explain why mammalian cells contain only trace amounts of 
CPE, as the substrates for CPE synthesis, PE, and ceramide are 
made in the ER.
We tested whether these substrates have limited access to 
the  enzyme’s  active  site.  SMSr  and  SMS1  share  a  common 
transmembrane domain organization with the active site facing 
the exoplasmic leaflet (Fig. 1 B; Huitema et al., 2004). SMSr-
catalyzed CPE production would therefore occur in the ER 
lumen. As ceramide is synthesized on the cytosolic surface of the 
ER (Mandon et al., 1992; Hirschberg et al., 1993), it could be 
scavenged by CERT before being able to flip to the site of CPE 
production. To test this, we used CHO-K1–derived LY-A mutant 
cells, which are defective in CERT-mediated ceramide transport 
(Hanada et al., 2003). As shown in Fig. 2 G, [
3H]sphingosine 
labeling of CHO-K1 and LY-A cells yielded similar levels of   
Figure 1.  SMSr proteins display CPES activity. (A) Phylogenetic tree of SMS family members from Homo sapiens (h), Xenopus tropicalis (x), Fugu rubripes 
(f), Drosophila (d), Apis mellifera (a), and C. elegans (c). The tree was constructed using ClustalX. (B) SMSr proteins share a common domain structure with 
vertebrate SMS1, which includes six transmembrane helices, an active site consisting of conserved His (H) and Asp (D) residues, and a N-terminal SAM 
domain. (C) TLC separation of reaction products formed when NBD-Cer was incubated with lysates of yeast strains expressing hSMSr or dSMSr or trans-
fected with empty vector (control). White line indicates that intervening lanes have been spliced out. (D) Yeast strains expressing hSMSr or dSMSr produce 
CPE in vivo. Different molecular species of CPE were detected by electrospray LC/MS/MS (neutral loss of 141) after alkaline hydrolysis of glycerolipids. 
No CPE was detected in lipid extracts of control (untransfected) yeast.JCB • VOLUME 185 • NUMBER 6 • 2009   1016
over rate of CPE in HeLa cells was similar to that of SM 
(unpublished data). Thus, the low CPE content of mammalian 
cells is unlikely the result of CPE being a short-lived meta-
bolic intermediate.
Together, these results suggest that SMSr proteins are in-
trinsically unable to produce bulk amounts of CPE. This is con-
sistent with our finding that CPE levels in SMSr-expressing yeast 
strains are invariably low (≤0.5 mol% of total phosphosphingo-
lipid). As bulk amounts of CPE are present in Drosophila, 
to  SM  production,  HeLa  cells  were  metabolically  labeled 
with D4-ethanolamine and D9-choline simultaneously. MS/MS 
analysis showed that the D4/D9 ratio of SM after 24-h labeling 
was 1:100, indicating that headgroup transfer from PC is the 
major pathway of SM biosynthesis. Moreover, the D4-labeled 
SM pool most likely originated from headgroup transfer of 
D4-labeled PC, as this pool was reduced by depletion of human 
SMS1  (unpublished  data).  Finally,  pulse-chase  experiments 
with [
14C]ethanolamine and [
14C]choline showed that the turn-
Figure 2.  Mammalian cells synthesize only trace amounts of CPE despite the ER residency of SMSr. (A) TLC analysis of reaction products formed when 
lysates of control (untransfected [untransf]) or hSMSr-V5–expressing HeLa cells were incubated with NBD-Cer. (B) TLC analysis of reaction products formed 
when NBD-Cer was incubated with lysates of HeLa cells expressing hSMSr-V5 in the presence or absence of externally added PE or PC. (C) Expression 
of hSMSr-V5 stimulates CPES activity in HeLa cells. CPES and SMS activity levels were determined by TLC analysis of reaction products formed when cell 
lysates were incubated with NBD-Cer and expressed relative to control cells. (D) CPES and SMS activity levels were determined in lysates of HeLa cells 
treated for 7 d with siRNA-targeting LA (si LA) or siRNA-targeting hSMSr (si hSMSr) or with nonsilencing siRNA (si NS) as in C and expressed relative to 
si LA–treated cells. (E) Confocal sections of HeLa cells were transfected with hSMSr-V5 or an SAM-deficient truncation mutant, hSMSrSAM-V5, and 
immunolabeled for V5. Note that removal of SAM causes hSMSr-V5 to redistribute from the ER to the Golgi. Bars, 5 µm. (F) Human Caco-2, Hep-G2, HeLa, 
hSMSrSAM-V5-expressing HeLa, and Drosophila S2 cells were labeled with [
14C]ethanolamine for 48 h and subjected to lipid extraction, TLC analysis, 
and autoradiography. In some extracts, glycerolipids were deacylated by mild alkaline hydrolysis (hydr; +). (G) Chinese hamster CHO-K1, CHO-K1– 
derived LY-A (CERT mutant), and LY-A/human CERT cells (mutant expressing human CERT) were labeled with [
3H]sphingosine for 24 h and subjected to lipid 
extraction, TLC analysis, and autoradiography. Error bars indicate SD; n = 3.1017 SMSr CONTROLS CERAMIDE HOMEOSTASIS IN THE ER • Vacaru et al.
with a GFP-tagged version of the ER marker PE N-methyltrans-
ferase (PEMT; PEMT-GFP) but not with the Golgi microtubule-
associated protein dGMAP (Fig. 3, A and B). The ER residency 
of dSMSr was confirmed by quantitative immunoelectron micros-
copy (Fig. 3, C and D). As observed for hSMSr, removal of its 
SAM domain caused dSMSr to redistribute from the ER to the 
Golgi (Fig. S2, C–E), which is consistent with a fundamental role 
of SAM in ER retention of SMSr proteins.
We next investigated the contribution of dSMSr to CPE 
production in S2 cells. Incubation of S2 cell lysates with NBD-
Cer led to formation of NBD-CPE (Fig. 4 A). NBD-CPE forma-
tion increased fivefold after overexpression of dSMSr. Mutation 
we next addressed the contribution of dSMSr to CPE production 
in Drosophila S2 cells.
Bulk production of CPE in insect cells is 
independent of SMSr
We first analyzed the subcellular distribution of dSMSr in S2 cells 
by using an antibody that specifically cross reacted with dSMSr 
on immunoblots of S2 cell extracts (see Fig. 4 C). As the endoge-
nous protein was hardly detectable by immunofluorescence 
microscopy, S2 cells were transfected with a Cu
+2-inducible dSMSr 
construct, and expression of the protein was enhanced fivefold (as 
indicated by immunoblotting). dSMSr colocalized extensively 
Figure 3.  dSMSr resides in the ER of insect cells. (A) Confocal sections of Drosophila S2 cells were double transfected with native dSMSr and ER marker 
PEMT-GFP and immunolabeled for dSMSr. (B) Confocal sections of S2 cells were transfected with untagged dSMSr and double labeled for dSMSr and 
cis-Golgi marker dGMAP. (A and B) Arrows indicate nuclear envelope staining. Bars, 5 µm. (C) Localization of dSMSr by immunoelectron microscopy is 
shown. Ultrathin cryosections of S2 cells transfected with dSMSr were double labeled for dSMSr (15-nm gold) and dSec23 (tER site marker; 10-nm gold). 
G, Golgi stack; N, Nucleus; E, endosome. Bar, 500 nm. (D) Quantification of immunogold labeling of S2 cells cotransfected with dSMSr and PEMT-GFP. 
Low-expressing cells are those with <40 gold particles per cell section; high-expressing cells are those with ≥40 gold particles per cell section.JCB • VOLUME 185 • NUMBER 6 • 2009   1018
did not enhance NBD-CPE production in HeLa cell lysates   
(Fig. 4 E, bottom).
In sum, insect cells contain two distinct CPESs: a PE/ceram-
ide ethanolamine phosphotransferase corresponding to dSMSr and 
a dSMSr-unrelated CDP-ethanolamine/ceramide ethanolamine 
phosphotransferase that is likely responsible for bulk production of 
CPE. Importantly, these findings confirm that SMSr proteins in 
general lack the ability to produce bulk amounts of CPE.
Blocking SMSr catalytic activity causes 
ceramide accumulation in the ER
Although SMSr produces only trace amounts of CPE, SMSr-
depleted HeLa cells showed a fourfold increase in ceramide 
levels (from 0.31 ± 0.01 to 1.29 ± 0.15 mol%; n = 3). This was 
accompanied by a threefold increase in GlcCer levels (from 
0.32 ± 0.03 to 0.86 ± 0.09 mol%; n = 3; Fig. 5 A). Depletion of 
SMS1 caused a very similar rise in ceramide and GlcCer levels. 
In the latter case, however, this can be fully explained by a block 
in SM production (Tafesse et al., 2007). In contrast, the amount 
of ceramide and GlcCer accumulating in SMSr-depleted HeLa 
of active site residues His401 or Asp405 abolished dSMSr-
mediated CPES activity (Fig. 4 A). Depletion of endogenous 
dSMSr resulted in a 60–70% drop in cell lysate–associated CPES 
activity (Fig. 4 B, left). Surprisingly, no significant reduction in 
CPE production levels was found when intact dSMSr-depleted 
S2 cells were metabolically labeled with NBD-Cer (Fig. 4 B, 
right) or [
14C]ethanolamine (Fig. 4 D), although the RNAi treat-
ment reduced dSMSr protein levels by 90% (Fig. 4 C). These 
results suggest that S2 cells are able to produce CPE through a 
second, dSMSr-independent enzyme.
One reason why this second enzyme is not readily detect-
able in cell lysates might be that it requires a soluble substrate that 
is continuously regenerated in living cells. CDP-ethanolamine is 
an attractive candidate for such a substrate given its role as head-
group donor in PE biosynthesis (Vance, 2008). Indeed, CPE 
production in S2 cell lysates increased dramatically after addi-
tion of CDP-ethanolamine provided that Mn
2+ ions were pres-
ent (Fig. 4 E, top). The CDP-ethanolamine–dependent CPES   
activity was unaffected by dSMSr depletion (Fig. 4 F) and 
appears unique for insect cells, as addition of CDP-ethanolamine 
Figure 4.  Bulk production of CPE in insect cells is independent of SMSr. (A) TLC analysis of reaction products formed when NBD-Cer was incubated with 
lysates of Drosophila S2 cells expressing dSMSr-V5, active site mutants of dSMSr-V5 (H401A and D405E), hSMSr-V5, active site mutant of hSMSr-V5 
(D348E), or SAM-deficient hSMSr-V5 (hSMSrSAM-V5). (B) S2 cells treated with ds GFP or dSMSr (ds dSMSr #1 or #2) for 7 d were metabolically labeled 
with NBD-Cer (intact cells) or lysed and incubated with NBD-Cer for 2 h (cell lysates). CPES activity levels were determined by TLC analysis and expressed 
relative to mock-treated cells. Error bars indicate SD; n = 3. (C) Immunoblots of S2 cells treated with dsRNA as in B were stained for dSMSr and dGol-
gin245. Note that the anti-dSMSr antibody cross reacts weakly with a dSMSr-unrelated protein (asterisk). (D) S2 cells treated with dsRNA as in B were 
metabolically labeled with [
14C]ethanolamine ([
14C]eth) for 2 h and subjected to TLC analysis and autoradiography. (E) TLC analysis of products formed 
in S2 (top) or HeLa cell lysates (bottom) when incubated with 50 µM NBD-Cer in the presence or absence of 500 µM CDP-ethanolamine (CDP-ethanol),   
5 mM MgCl2, or 10 mM MnCl2. (F) TLC analysis of products formed in lysates of dsRNA-treated S2 cells incubated with NBD-Cer and MnCl2 in the pres-
ence or absence of CDP-ethanolamine as in E.1019 SMSr CONTROLS CERAMIDE HOMEOSTASIS IN THE ER • Vacaru et al.
by the COPII subunit dSec23) was maintained, both structures 
had a fragmented, hazy appearance (Fig. 6 A; and Fig. S4, A–I). 
This effect was quantitative, as more than half of the depleted 
cells displayed a fragmented Golgi (Fig. 7 C). However, the global 
architecture of the ER was unaffected by the depletion.
At the ultrastructural level, Golgi morphology in dSMSr-
depleted S2 cells was profoundly affected. Instead of showing 
the typical organization of stacked cisternae (Fig. 6, B and D), 
the Golgi was converted into many short tubular structures in the 
majority of the cells (Fig. 6, C, E, and F). These tubular clusters 
were mostly devoid of KDEL-containing proteins but were posi-
tive for dSec23 (Fig. 6, E and F), suggesting that they represent 
a mixture of Golgi and tER membranes.
hSMSr-depleted HeLa cells showed a very similar pheno-
type. The Golgi ribbon was completely fragmented in more than 
half of the cells as indicated by immunostaining against markers 
of medial (MannII-RFP) and trans-Golgi compartments (TGN46; 
Fig. 6 G; Fig. 7 C; Fig. S4, J–L). These results further strengthen 
the functional similarity between hSMSr and dSMSr. Moreover, 
the requirement of SMSr for Golgi integrity appears specific be-
cause  the  Golgi  ribbon  was  unperturbed  in  hSMS1-depleted 
HeLa cells (Fig. 6 G).
We next tested whether fragmentation of the early secretory 
pathway could result in or be the result of inhibition of anterograde 
transport. To this end, we monitored the transport efficiency of the 
transmembrane protein Delta from the ER to the PM in S2 cells 
(Kondylis and Rabouille, 2003). Brefeldin A treatment blocked 
PM delivery of Delta and caused its accumulation in the ER. 
In contrast, PM delivery of Delta was not significantly impaired in 
dSMSr-depleted S2 cells, suggesting that the fragmented tER–
Golgi units in these cells are fully competent for anterograde trans-
port (Fig. S5 A). Similar results were obtained in hSMSr-depleted 
HeLa cells using the well-established VSV-045G transport assay 
(Fig. S5, C and D). Moreover, SMSr depletion had no major impact 
on protein glycosylation (Fig. S5 E). Together, these findings indi-
cate that SMSr proteins play a critical role in the acquisition of 
Golgi stack morphology without affecting the functional integrity 
of the organelle. This adds further evidence to the notion that trans-
port of cargo to, through, and out of the Golgi complex does not re-
quire a fully developed organelle and can proceed under conditions 
in which the cisternal stacks are severely disorganized (Kondylis 
and Rabouille, 2003; Zolov and Lupashin, 2005).
Golgi fragmentation in SMSr-depleted  
cells is caused by ceramide accumulation  
in the ER
To test whether catalytic activity of SMSr is required to prevent 
Golgi fragmentation, we monitored the rescue of this phenotype by 
transfecting dSMSr-depleted S2 cells with wild-type or enzyme-
dead hSMSr. Expression of wild-type hSMSr almost completely 
restored Golgi integrity. However, mutation of active site residue 
Asp348 to Glu was sufficient to abolish the rescuing effect (Fig. 7, 
A and C). These results completely parallel those obtained with 
hSMSr-depleted HeLa cells after transfection with siRNA-resistant 
hSMSr or hSMSr
D348E (Fig. 7, B and C).
One possible interpretation of these results is that the struc-
tural integrity of the early secretory pathway depends on the trace 
cells is 50-fold higher than can be ascribed to a block in CPE 
production (Fig. 5 A). The rise in ceramides affected all major 
species (Fig. S3 A and Table S1), could also be detected by 
[
14C]serine labeling, and was not accompanied by an increase in 
sphingosine levels (Fig. S3 C). Moreover, it also occurred in 
SMSr-depleted hamster CHO-K1 and Drosophila S2 cells, al-
though in the latter case to a lesser extent (Fig. S3 B).
As SMSr resides in the ER, the ceramide accumulation in 
SMSr-depleted cells likely originates from this organelle. This 
was confirmed by subcellular fractionation, which showed that 
the ER of SMSr-depleted HeLa cells contains nearly 300% more 
ceramide than the ER of lamin A (LA)–depleted control cells 
(Fig. 5, B and C). To verify this also for S2 cells, we created an 
ER-resident form of hSMS1 and analyzed its ability to reduce 
ceramide levels in dSMSr-depleted S2 cells. Consistent with a role 
of SMSr-derived SAM in ER retention, an hSMS1 swap mutant 
carrying the SAM-containing cytosolic tail of hSMSr, hSMS1Nr, 
localized primarily to the ER (Fig. 5, D and E). hSMS1Nr 
retained its SMS activity, as its expression in S2 cells sup-
ported production of SM (Fig. 5 F). Expression of ER resident 
hSMS1Nr but not Golgi-associated hSMS1 prevented the ac-
cumulation of [
14C]serine-labeled ceramides in dSMSr-depleted 
S2 cells (Fig. 5 G). Together, these results indicate that SMSr acts 
as a negative regulator of ceramide levels in the ER.
To investigate whether SMSr requires its catalytic activity to 
prevent ceramide accumulation, dSMSr-depleted S2 cells were 
transfected with wild type or an enzyme-dead version of hSMSr. 
Expression of wild-type hSMSr effectively reduced the ceramide 
pool in dSMSr-depleted S2 cells (Fig. 5 H). However, mutation of 
active site residue Asp348 to Glu was sufficient to abrogate this 
effect. Transfection of hSMSr-depleted HeLa cells with siRNA-
resistant hSMSr or hSMSr
D348E yielded the same results (Fig. 5 H). 
Thus, even though SMSr produces only trace amounts of CPE, 
this appears essential to control the ceramide pool in the ER.
Loss of SMSr perturbs the organization  
of the early secretory pathway
Recent work revealed that CERT
/ mouse embryos accumulate 
ceramide in the ER and display a chronic state of ER stress char-
acterized by vesiculation and engorgement of the ER and up-
regulation of downstream components of the unfolded protein 
response pathway (Wang et al., 2009). Even though SMSr-
depleted S2 and HeLa cells show a substantial rise in ER cer-
amide levels, they did not display any of the morphological (ER 
dilation and vesiculation) or biochemical (XBP-1 splicing, induc-
tion of CHOP/GADD153, and up-regulation of ER chaperones) 
features of ER stress (unpublished data). Instead, we found that 
the organization of ER exit sites and the Golgi complex was 
greatly perturbed.
Golgi stacks in S2 cells do not form a large Golgi ribbon 
capping the nucleus as in mammalian cells. Instead, they remain 
discrete in the cytoplasm and are found in close proximity to tran-
sitional ER (tER) sites, forming 17–25 tER–Golgi units (Kondylis 
and Rabouille, 2003; Kondylis et al., 2007). In dSMSr-depleted 
S2 cells, the tER–Golgi units were much smaller and more 
numerous than in mock-depleted cells. Though the spatial relation-
ship between the Golgi (marked by d120kd) and tER sites (marked JCB • VOLUME 185 • NUMBER 6 • 2009   1020
Figure 5.  SMSr-depleted cells accumulate ceramides in the ER. (A) HeLa cells treated with si LA, si hSMSr, or siRNA-targeting hSMS1 (si hSMS1) for 3 d 
were subjected to lipid extraction. Lipid classes were quantified by MS/MS analyses and expressed in mole percent of total lipid analyzed. Data shown 
are representative of three independent experiments. (B) HeLa cells expressing hSMS1-V5 were subjected to subcellular fractionation, yielding a PNS 
and fractions enriched for mitochondria (mito)/Golgi, PM/early endosomes (EE), or ER. Equal amounts of protein from each fraction were analyzed by 
immunoblotting. Note that the ER fraction was virtually free of other organelles except for a minor contamination with PM (<10%). (C) MS/MS analysis 
of ceramide and PE levels in ER fractions prepared from HeLa cells treated with si LA or si hSMSr for 3 d. (D) HeLa cells transfected with hSMS1-V5 or 
an hSMS1 swap mutant carrying the N-terminal tail of hSMSr, hSMS1Nr-V5, were double labeled for V5 and cis-Golgi marker GM130. (E) S2 cells 
cotransfected with hSMS1-V5 or hSMS1Nr-V5 and ER marker PEMT-GFP were labeled for V5. The white box marks a cell captured from a different field. 
Note that hSMS1Nr-V5 localizes to the ER and nuclear envelope (D and E, arrows). (F) S2 cells transfected with hSMS1-V5 or hSMS1Nr-V5 were labeled 
with [
14C]choline for 5 h and subjected to lipid extraction, TLC, and autoradiography. (G) dSMSr-depleted S2 cells were transfected with hSMS1-V5 or 
hSMS1Nr-V5 and labeled for 5 h with [
14C]serine. Levels of radiolabeled ceramides were determined by TLC and autoradiography and expressed as a 
percent of mock-treated cells. (H) SMSr-depleted cells (S2/HeLa) were transfected with hSMSr-V5 or hSMSr
D348E-V5 and labeled for 5 h with [
14C]serine. 
Levels of radiolabeled ceramides were determined as in G. SMSr depletions were with ds dSMSr #2 (S2) or si hSMSr #2 (HeLa). Transfection of HeLa cells 
was with siRNA-resistant (res) hSMSr constructs. Untransf, untransfected. Error bars: (G) SD, n = 3; (C and H) range, n = 2.1021 SMSr CONTROLS CERAMIDE HOMEOSTASIS IN THE ER • Vacaru et al.
Figure 6.  SMSr depletion disrupts tER–Golgi units in insect and mammalian cells. (A) S2 cells were treated for 7 d with ds GFP, ds dSMSr #1, or ds dSMSr 
#2 and double labeled for dSec23 (tER sites) and d120kd (Golgi stacks). Confocal projections of the merge are presented. The single channels are pre-
sented in Fig. S5 A. Bar, 5 µm. (B–F) S2 cells treated for 5 d with ds GFP (B and D) or dSMSr #2 (C, E, and F) were fixed and processed for immunoelectron 
microscopy. Ultrathin cryosections were visualized before (B and C) or after double labeling for dSec23 (15-nm gold) and KDEL (10-nm gold; D–F). Note 
that Golgi stacks in most dSMSr-depleted cells are converted to a cluster of short tubular profiles (arrowheads) in cytoplasmic regions normally occupied by 
tER–Golgi units (between brackets). These short tubules are positively labeled for Sec23, suggesting that they comprise membrane of both compartments. 
G, Golgi stack. (G) Mannosidase II-RFP–expressing HeLa cells were treated with si LA, si hSMSr #2, or hSMS1 for 3 d and labeled for TGN46 and DNA 
(DAPI). Confocal projections of the merge are presented. The single channels are presented in Fig. S5 (J–L). Bars: (A and G) 5 µm; (B–F) 200 nm.JCB • VOLUME 185 • NUMBER 6 • 2009   1022
Figure 7.  Structural integrity of tER–Golgi units requires an enzyme-active form of SMSr. (A) S2 cells were treated with ds SMSr #2 and transfected with 
hSMSr-V5 or hSMSr
D348E-V5. After 7 d, cells were double labeled for Golgi marker dGMAP and V5 to mark transfected cells. Confocal projections are 
presented. Note that cells expressing hSMSr (arrows) mostly show the typical wild-type Golgi organization of 17–25 large spots. In contrast, nontransfected 
cells or those expressing enzyme-dead hSMSr (arrowheads) typically have more numerous and smaller Golgi spots. (B) Mann II-RFP–expressing HeLa 
cells were treated with si hSMSr #2 and transfected with siRNA-resistant (res) hSMSr-V5 or hSMSr
D348E-V5. After 3 d, cells were labeled for V5 to mark 
transfected cells. Confocal projections are presented. Note that cells expressing hSMSr-V5 contain an intact Golgi (arrows). In contrast, cells expressing 
enzyme-dead hSMSr still have fragmented Golgi (arrowheads). (C) Quantitation of the rescue of the Golgi fragmentation phenotype in SMSr-depleted 
cells (HeLa/S2) after transfection of wild-type or enzyme-dead SMSr. SMSr-depleted cells are compared with control cells (si LA or ds GFP treated), and 1023 SMSr CONTROLS CERAMIDE HOMEOSTASIS IN THE ER • Vacaru et al.
amounts of CPE produced by SMSr. Alternatively, as an enzyme-
dead mutant of SMSr is unable to prevent ceramide accumulation 
in the ER (Fig. 5 H), fragmentation of the early secretory pathway 
in SMSr-depleted cells could be caused by the rise in ceramide 
levels in the ER. To distinguish between these possibilities, 
ER resident SMS hSMS1Nr was expressed in SMSr-depleted S2 or 
HeLa cells and analyzed for its ability to rescue Golgi fragmenta-
tion. Expression of hSMS1Nr partially restored Golgi integrity in 
both cell types (Fig. 7 D), indicating that acquisition of Golgi 
stack morphology is not strictly dependent on production of CPE. 
As expression of hSMS1Nr was effective in preventing ceramide 
accumulation in SMSr-depleted cells (Fig. 5 G), we asked whether 
blocking ceramide production or stimulating ceramide export 
from the ER would also suppress Golgi fragmentation. Treatment 
with ceramide synthase inhibitor fumonisin B1 or overexpression 
of CERT partially but reproducibly restored Golgi integrity in 
both SMSr-depleted HeLa and S2 cells (Fig. 7 D). This indicates 
that  the  structural  collapse  of  the  early  secretory  pathway  in 
SMSr-depleted cells is the result of ceramide accumulation in 
the ER. Thus, these results further support a primary role of SMSr 
in controlling ceramide homeostasis in the ER.
Discussion
SMSr proteins define an unconventional 
class of sphingolipid synthases
In this study, we show that SMSr, the most conserved member of 
the multigenic SMS family, catalyzes production of the SM ana-
logue CPE. SMSr likely accounts for the CPES activity described 
two decades ago in rat brain and liver microsomes (Malgat et al., 
1986, 1987). Common features between these enzymes include 
the use of PE as headgroup donor, their ER residency, and a mem-
brane topology in which the active site is facing the ER lumen. 
Although mammalian cells contain a readily detectable CPES 
activity, their CPE content is very low (i.e., 300-fold lower than 
SM). This enigma is neither caused by a limited supply of sub-
strates to the enzyme’s active site nor by CPE being a short-lived 
metabolic intermediate. Instead, we find that SMSr intrinsically 
lacks the ability to synthesize significant amounts of CPE. This is 
radically different from closely related SMS1, which catalyses 
bulk production of SM (Tafesse et al., 2007).
What makes SMSr so different from SMS1? SMS1 uti-
lizes a lipid phosphate phosphatase–type reaction mechanism, 
which involves a single lipid-binding site and proceeds via trans-
fer of phosphocholine from PC to a conserved histidine in the 
enzyme’s active site (Huitema et al., 2004; Tafesse et al., 2006). 
When DAG is replaced by ceramide, the phosphocholine head-
group is transferred onto ceramide to form SM. The latter is then 
released from the active site to allow another round of catalysis. 
Mutational analysis of putative active site residues indicates that 
SMSr-mediated CPE production involves a very similar reaction 
mechanism. However, although SM readily dissociates from 
SMS1, we propose that CPE remains bound to the active site of 
SMSr, thus blocking a further round of catalysis. This could be the 
result of several factors. First, SMSr might have a higher affinity 
for CPE than for PE. Second, dissociation of SM from SMS1 
might be facilitated by its preferential interaction with cholesterol. 
Contrary to SM, CPE lacks this interaction (Terova et al., 2005). 
Thus, in the presence of cholesterol, SM production might be 
thermodynamically more favorable than CPE production.
The notion that SMSr is unable to produce significant 
amounts of CPE is further substantiated by our finding that bulk 
production of CPE in insects is mediated by a different enzyme. 
This second CPES uses CDP-ethanolamine instead of PE as 
headgroup donor, which is analogous to the ethanolamine phospho-
transferases of the Kennedy pathway (Vance, 2008). This implies 
that, contrary to SM synthesis in mammals, bulk production of 
CPE occurs in the cytosolic leaflet of the membrane. As insects 
require CERT for efficient CPE production (Rao et al., 2007), 
the second enzyme likely resides in the Golgi.
SMSr qualifies for a ceramide sensor  
in the ER
Although SMSr is a poor CPES, we find that the enzyme has a 
major impact on ceramide levels in the ER. Indeed, SMSr- 
depleted mammalian cells display a rise in ceramide levels that is 
one order of magnitude too high to be explained by a reduced 
ceramide consumption for CPE biosynthesis. SMSr-depleted in-
sect cells and SMSr-null mutants in Caenorhabditis elegans also 
show a marked increase in ceramide levels (this study; unpub-
lished data). Strikingly, a single point mutation in the active site 
of SMSr proved sufficient to induce ceramide accumulation. This 
shows that SMSr must be catalytically active to keep ER cer-
amide levels low, even if the enzyme lacks the ability to consume 
significant amounts of ceramide. Together, these results establish 
SMSr as a novel regulator of ceramide homeostasis in the ER.
How does SMSr control ceramide levels in the ER? We   
anticipate that under normal conditions, only small amounts of 
ceramide will reach the enzyme’s active site. This is because cer-
amides synthesized on the cytosolic surface of the ER are con-
tinuously removed by CERT (Fig. 8 A). Consequently, only a 
minor fraction of SMSr enzymes will be trapped in a CPE-bound 
form. Yet when the rate of ceramide production exceeds ceramide 
removal by CERT, the pool of CPE-bound enzymes will expand. 
It is possible that CPE-bound SMSr adopts a conformation that 
relays a signal to inhibit ceramide biosynthesis and/or stimulate 
ceramide degradation (Fig. 8 B). Alternatively, SMSr-derived 
CPE might directly influence the activity of ceramide-metabolizing 
enzymes in the ER. Either feedback mechanism would ensure 
maintenance of ceramide homeostasis in the ER. Distinguishing 
between these possibilities will require reconstitution experi-
ments with purified enzymes.
SMSr-depleted cells transfected with wild-type or enzyme-dead SMSr are compared with untransfected (untransf) SMSr-depleted cells. (D) Quantification 
of the rescue of the Golgi fragmentation phenotype in SMSr-depleted cells (Hela/S2) after transfection with hSMS1Nr-V5 or CERT-Flag or after treatment 
with 50 µg/ml fumonisin B1 (FB1) for 2 d (HeLa) or 5 h (S2) before fixation. SMSr-depleted cells expressing hSMS1Nr-V5 or CERT-Flag are compared 
with untransfected cells, and mock-treated cells are compared with FB1-treated cells. Errors bars indicate SD, n = 3. *, P < 0.001 by two-tailed unpaired 
Student’s t test. Bars, 5 µm.
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they grow large enough to produce COPII vesicles. A rise in ER 
ceramides may perturb the local physical environment required to 
stabilize patches of tER proteins. Alternatively, ceramides may 
affect tER site morphology by altering the membrane turnover of 
COPII components analogous to the situation in sterol-depleted 
cells (Runz et al., 2006). Moreover, ceramides serve as early medi-
ators of apoptosis, an event accompanied by fragmentation of the 
Golgi complex. Apoptosis-induced Golgi fragmentation requires 
caspase 3–mediated cleavage of golgins, a family of coiled-coil 
proteins involved in maintenance of Golgi stack morphology (Lane 
et al., 2002). Interestingly, SMSr-depleted HeLa cells display hall-
marks of apoptosis, including activation of caspase 3 (unpublished 
data). Whether blocking caspase activation prevents Golgi frag-
mentation in SMSr-deficient cells remains to be established.
A tight regulation of ceramide homeostasis in the ER likely 
has functional implications beyond sustaining the structural 
integrity of the early secretory pathway. Down-regulation of CERT 
sensitizes cancer cells to paclitaxel, suggesting that ER ceramides 
are integral to taxane-induced cell death (Swanton et al., 2007). 
Moreover, CERT
/ mouse embryos accumulate ceramide in the 
ER and display a chronic state of ER stress (Wang et al., 2009). 
As components of the unfolded protein response are up-regulated 
during animal development (Reimold et al., 2000; Iwakoshi et al., 
2007), a defective transport of ceramide might potentiate ER 
stress in the embryo (Wang et al., 2009). Whether loss of SMSr 
sensitizes cells to ER stress–inducing conditions is currently 
under investigation.
The ER is a highly efficient lipid distribution system that is 
intimately associated with other organelles, including mitochon-
dria (Levine and Rabouille, 2005). Ceramides have been impli-
cated in mitochondria-induced apoptosis and may reach these 
organelles via contact sites with the ER (Siskind et al., 2008; 
Stiban et al., 2008; Wang et al., 2009). The present identification 
of SMSr as a key regulator of ceramide homeostasis in the ER 
provides novel opportunities to explore the role of ceramides in 
mitochondria-induced cell death and for modulating taxane 
effects on tumors.
Collectively, our data suggest that SMSr is a CPES with a 
dual role as ceramide sensor to control ceramide homeostasis in 
the ER. As its active site faces the ER lumen, SMSr would only 
sense ceramides present in the exoplasmic leaflet, i.e., molecules 
that escaped CERT-mediated extraction at the cytosolic surface 
and flipped to the lumenal side. Notably, this arrangement implies 
cooperativity between SMSr and CERT in keeping ER ceramide 
levels low. Thus, SMSr serves a biological role that is different 
from closely related SMS1 but analogous to the ensemble of 
membrane proteins that monitor sterol concentrations in the ER 
(Goldstein et al., 2006). In this respect, the SMS enzyme family 
displays an interesting parallel with the nutrient transporter family. 
Besides conventional transporters, the latter family also harbors 
transceptors that play a dual role as nutrient sensor because their 
conformational change during the transport process can trigger 
downstream signaling pathways (Holsbeeks et al., 2004).
Functional implications of SMSr-controlled 
ceramide homeostasis
Concurrent with the accumulation of ceramide in the ER, blocking 
SMSr activity causes a structural collapse of the early secretory 
pathway. The disruption of tER–Golgi organization completely 
parallels the rise in ER ceramide levels. Indeed, any condition that 
normalizes the ceramide concentration in the ER seems to restore 
Golgi stack morphology; i.e., the presence of enzymatically active 
SMSr, the consumption of ceramide by ER resident SMS, stimula-
tion of ER export of ceramide by overexpression of CERT, or a 
block in ceramide production by ceramide synthase inhibitors. 
Conversely, blocking SM production to accumulate ceramides in 
the Golgi does not perturb its morphology.
How can an excess of ceramides in the ER affect Golgi orga-
nization? As the biogenesis of the Golgi is tightly linked to that of 
tER sites (Bevis et al., 2002), a disruption of tER sites likely con-
tributes to the structural collapse of the Golgi. tER sites are thought 
to arise from patches of ER membrane proteins that have weak, 
cooperative affinity for one another (Bevis et al., 2002; Heinzer   
et al., 2008). These patches capture additional tER proteins until 
Figure 8.  Model of how SMSr might control ceramide homeostasis in the ER. (A) Normally, only small amounts of newly synthesized ceramides can reach 
the active site of SMSr in the ER lumen as a result of their efficient removal from the cytosolic surface by CERT. (B) When CERT can’t cope with the rate of 
ceramide production, more ceramides will reach the active site of SMSr, resulting in production of CPE. Because of its high affinity for the enzyme’s 
active site, CPE remains bound to SMSr, thus blocking a further round of catalysis. CPE-trapped SMSr adopts a conformation that relays a signal inhibiting 
ceramide production or stimulating ceramide breakdown in the ER, thereby restoring ceramide homeostasis. Sph, sphingoid base.1025 SMSr CONTROLS CERAMIDE HOMEOSTASIS IN THE ER • Vacaru et al.
CTGGAATTTCTTGC-3; hSMS1, 5-AACTACACTCCCAGTACCTGG-3. 
For rescue experiments, cells were transfected with siRNA-resistant hSMSr 
constructs 8 h after the start of siRNA treatment using Effectene (QIAGEN). 
Constructs were made siRNA resistant by introducing five silent point muta-
tions in the siRNA target sequence.
Drosophila S2 cells were grown in Schneider’s insect medium with 
10% FBS. Treatment with double-stranded RNA (dsRNA) was performed 
as described previously (Clemens et al., 2000). On day 1, 10
6 cells were 
plated in a 35-mm dish and incubated with 30 µg dsRNA in 1 ml serum-
free medium for 1 h at RT followed by addition of 2 ml complete medium. 
Treatment with dsRNA was repeated on day 4. For rescuing experiments, 
cells were transfected with SMS/pMT/V5-HisB constructs on day 5 using 
Effectene. Expression of recombinant SMS protein was induced by addi-
tion of 1 mM CuSO4 for 3 h followed by a 2-h chase in the presence of   
150 µg/ml cycloheximide. dsRNA was synthesized by in vitro transcription 
of PCR products flanked by T7 RNA polymerase-binding sites (5-TTAATAC-
GACTCACTATAGGGAGA-3) using the MEGASCRIPT T7 transcription 
kit (Applied Biosystems). dsRNA-targeting dSMSr was synthesized from 
two 800-bp PCR products that were generated from dSMSr cDNA using 
the  following  primer  sets:  5-T7-ATGTGCGACGGTGAAATTG-3/5-T7-
GAGCCGGTTATTTCGCACAT-3  (dsRNA-targeting  SMSr  [ds  SMSr]  #1) 
and  5-T7-TTGGTCCTACTGAGGCGATTC-3/5-T7-CGACTGGTGAG-
GACTAAAGAAAGC-3 (ds SMSr #2). dsRNA-targeting GFP (ds GFP) 
was synthesized from an 800-bp PCR product, which was generated 
from  pMT/EGFP  plasmid  using  the  primer  set  5-T7-CTAGGCGGCCG-
CAAAAAATG-3/5-T7-CTGTTCGAAGGCGCGCCTTGT-3.
In vitro enzyme assays
100 ODs of yeast cells was lysed by bead bashing in 10 ml ice-cold reac-
tion buffer (0.3 M sucrose, 15 mM KCl, 5 mM NaCl, 1 mM EDTA, 20 mM 
Hepes-KOH, pH 7.0) containing freshly added protease inhibitors. HeLa 
and S2 cells were lysed in ice-cold reaction buffer by passing 20 times 
through a 26-G 0.75 needle. 200 µl postnuclear supernatant (PNS; 700 g 
for 10 min at 4°C) was combined with 200 µl reaction buffer containing 
0.002% Triton X-100, 40 nmol POPE and/or POPC, and 50 µM NBD-Cer 
(Avanti Polar Lipids, Inc.), and incubated at 37°C (HeLa/yeast) or 27°C 
(S2 cells) for 2 h. Reactions were stopped by adding 1 ml MeOH and 0.5 ml 
CHCl3, and lipids were extracted according to Bligh and Dyer (1959). 
The lower phase was evaporated under N2 and the reaction products ana-
lyzed by TLC, which was developed first in acetone and then in CHCl3/
MeOH/25% NH4OH (50/25/6 [vol/vol/vol]; Figs. 1 and 2) or CHCl3/
acetone/MeOH/acetic  acid/H2O  (50/20/10/10/5  [vol/vol/vol/vol/
vol]; Fig. 4). Fluorescent lipids were visualized on an image analysis sys-
tem (STORM 860; GE Healthcare) and quantified with Quantity One soft-
ware (Bio-Rad Laboratories).
Lipid MS
100 ODs of yeast cells was washed with water, treated with trichloroacetic 
acid to inactivate lipases, and finally boiled for 10 min before lipid extrac-
tion by bead bashing in CHCl3/MeOH/H2O (10/10/3 [vol/vol/vol]) ac-
cording to Folch et al. (1957). HeLa and S2 lipid extracts were prepared 
according to Folch et al. (1957), but omitting the salt. The lower phase was 
evaporated under N2. Glycerolipids were removed by mild alkaline hydro-
lysis in 0.5 M sodium methoxide in MeOH for 1 h at RT. The lipids were 
analyzed with a triple quadrupole mass spectrometer (PE Sciex API-365; 
Applied Biosystems). Positive ions were generated by a turbo ion spray 
ionization source operating at +5.5 kV ionization potential. N2 was used 
as drying gas at 350°C. The declustering potential (cone voltage) was set 
to 50 V, the collision energy to 36 V, the entrance potential to 10 V, and 
the focus potential to 160 V. The lipid molecular species and classes were 
quantified as described previously in Tafesse et al. (2007).
Metabolic labeling
S2 cells (2–5 × 10
6) were labeled in 0.5 ml complete Schneider’s insect 
medium with 10 nmol NBD-Cer, 1 µCi [
14C]ethanolamine, 1 µCi [
14C]choline, 
or 1 µCi [
14C]serine at 27°C for the indicated time. Mammalian cells (10-cm 
dish; 50% confluency) were labeled in complete medium with 1 µCi 
[
14C]ethanolamine or 1 µCi [
3H]sphingosine for the indicated time. Lipids 
were extracted in CHCl3/MeOH/10 mM acetic acid (1/4.4/0.2 [vol/
vol/vol]) and processed according to Bligh and Dyer (1959). Half of the 
extract was subjected to mild alkaline hydrolysis. Radiolabeled lipids were 
analyzed by TLC in CHCl3/MeOH/25% NH4OH (50/25/6 [vol/vol/vol]; 
[
14C]ethanolamine/choline),  CHCl3/MeOH/2  M  NH4OH  (40/10/1 
[vol/vol/vol]; [
14C]serine), CHCl3/MeOH/0.2% CaCl2 (60/40/9 [vol/
vol/vol]; [
3H]sphingosine), detected by exposure to imaging screens (BAS-MS; 
Materials and methods
Chemicals
NBD-Cer was obtained from Invitrogen, NBD-SM, POPE (2-oleoyl-1-palmitoyl-
sn-glycerol-3-phosphoethanolamine),  and  POPC  (2-oleoyl-1-palmitoyl-sn-
glycerol-3-phosphocholine) were obtained from Avanti Polar Lipids, Inc. 
NBD-CPE was provided by P. Devaux (Institut de Biologie Physico-chimique, 
Paris, France). 2-[
14C]ethan-1-ol-2-amine hydrochloride and 3-[
14C]L-serine 
were obtained from GE Healthcare, and methyl-[
14C]choline chloride and 
[
3H]sphingosine  were  obtained  from  MP  Biomedicals.  D4-ethanolamine 
and D9-choline were obtained from Cambridge Isotope Laboratories. 
All other lipids and chemicals were obtained from Sigma-Aldrich.
Antibodies
The following antibodies were used: rabbit polyclonal anti-V5 and mouse 
monoclonal anti-Flag (Sigma-Aldrich), mouse monoclonal anti-V5 (Invitro-
gen), mouse monoclonal anti-GM130 (BD), mouse monoclonal anti-KDEL, 
rabbit polyclonal anti-calnexin and anti-GRP75 (Santa Cruz Biotechnology, 
Inc.), mouse monoclonal anti-d120kd (EMD), rabbit polyclonal anti-dGOL-
GIN245 (provided by S. Munro, Medical Research Council Laboratory of 
Molecular Biology, Cambridge, England, UK), rabbit polyclonal anti-Na
+/
K
+-ATPase (C356-M09; provided by J. Koenderink, Radboud University 
Nijmegen, Nijmegen, Netherlands), rabbit polyclonal antiprotein disulfide 
isomerase (provided by I. Braakman, Utrecht University, Utrecht, Nether-
lands),  rabbit  polyclonal  anti-GFP  (Invitrogen),  mouse  monoclonal  anti-
EEA1 (BD), rabbit polyclonal anti-dGMAP (Kondylis et al., 2007), rabbit 
polyclonal anti-dSec23p, and mouse monoclonal C594.9B (Kondylis and 
Rabouille,  2003).  Horseradish  peroxidase–conjugated  secondary  anti-
bodies were obtained from PerBio, whereas antibodies conjugated to FITC 
and Texas red or Alexa dyes were obtained from Jackson Immunoresearch 
Laboratories and Invitrogen, respectively.
To raise an antibody against dSMSr, the N terminus of dSMSr (resi-
dues 1–199) was expressed as glutathione S-transferase fusion in Esche-
richia coli and purified by affinity chromatography on glutathione agarose 
(Sigma-Aldrich). The purified fusion protein was used by PickCell Laborato-
ries for the immunization of mice, yielding monoclonal anti-dSMSr anti-
body B5-G7.
DNA constructs
hSMSr, hSMS1, and dSMSr cDNAs were cloned into yeast expression vec-
tor pYES2.1/V5-His-TOPO and mammalian expression vector pcDNA3.1/
V5-His-TOPO (Invitrogen) as described previously (Huitema et al., 2004). 
For expression studies in Drosophila S2 cells, dSMSr, hSMSr, and hSMS1 
cDNAs were PCR amplified and ligated into the copper-inducible pMT/
V5-His B vector (Invitrogen). Mutation of active site residues in dSMSr (H401A 
and D405E) and hSMSr (D348E) was performed using the megaprimer PCR 
method (Orr-Weaver et al., 1983). SAM-deficient mutants were obtained   
by truncation of the first 186 N-terminal residues in dSMSr or the first 68 
N-terminal residues in hSMSr. An ER-resident hSMS1 swap mutant, hSMS1Nr, 
was made by swapping the cytosolic N terminus of hSMS1 (residues 1–133) 
with that of hSMSr (residues 1–150). The cDNA of human PEMT was pur-
chased from RZPD (clone IRATp970D1078D6) and cloned into pMT/EGFP. 
Human CERT–Flag (Fugmann et al., 2007) and Drosophila CERT–Flag ex-
pression constructs (Rao et al., 2007) were provided by M. Olayioye (Uni-
versity of Stuttgart, Stuttgart, Germany) and J. Acharya (National Cancer 
Institute at Frederick, Frederick, MD), respectively.
Yeast culture
Yeast strain 4.Lass5 (MATa ade2-101
ochre his3-200 leu2-1 lys2-801
amber 
trp1-63  ura3-52  lag1::TRP1  lac1::LEU2  ydc1::natMX  ypc1::kanMX4 
p413MET25:Lass5; Cerantola et al., 2007) was transfected with hSMSr or 
dSMSr in pYES2.1/V5-His-TOPO and grown in selective synthetic medium 
containing 2% (wt/vol) galactose and 50 mg/l myo-inositol.
Animal cell culture and RNAi
CHO-K1 and LY-A cells were grown in F-12 medium with 10% FCS (Invitro-
gen), whereas LY-A/human CERT cells were grown in F-12 medium contain-
ing 0.8 mg/ml G-418 (Invitrogen). HepG2 cells were grown in DME with 
10% FBS (Cambrex) and CaCo-2 cells in DME-GlutamaxI with 10% FCS. 
HeLa cells were grown in DME with 10% FCS. Stable transfections with 
hSMS1-V5, hSMSr-V5, or mouse -mannosidase II-RFP in pcDNA3.1 and 
treatment with siRNA (QIAGEN) were performed as described previously 
(Tafesse et al., 2007). siRNA target sequences were: nonsense, 5-AATTC-
TCCGAACGTGTCACGT-3;  LA,  5-AACTGGACTTCCAGAAGAACA-3; 
hSMSr #1, 5-AATCTTCTTCATCTTGGCTGC-3; hSMSr #2, 5-CAAGAAG-JCB • VOLUME 185 • NUMBER 6 • 2009   1026
transport to the PM is not impaired in SMSr-depleted cells. Table S1 shows 
a quantitative analysis of ceramide species in control, hSMSr-depleted, 
and hSMS1-depleted HeLa cells. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200903152/DC1.
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Isolation of ER membranes
HeLa cells were washed twice and harvested by scraping in ice-cold 
homogenization buffer (HB; 10 mM Hepes, pH 7.8, 1 mM EGTA, 25 mM 
KCl, 1 mM protease inhibitor cocktail, and 1 mM PMSF) supplemented with 
0.25 M sucrose. Cells were pelleted by centrifugation at 600 g and gently 
disrupted by a dounce homogenizer in 11 ml HB at 4°C. The homogenate 
was centrifuged twice at 500 average g (gav; 5 min at 4°C) to generate a 
PNS. The PNS was centrifuged at 10,000 gav (10 min at 4°C) to pellet mito-
chondria. The postmitochondrial supernatant was loaded onto a 1 ml 68% 
(wt/wt) sucrose cushion (prepared in HB) and centrifuged at 100,000 gav. 
(1 h at 4°C) to collect crude microsomes. The microsomes were resuspended 
in 1 ml HB and loaded on top of a 25–60% (wt/wt) sucrose step gradient 
that was generated in HB using the following steps: 2 ml 25%, 2 ml 30%, 
2 ml 37%, 2 ml 39%, 2 ml 42%, and 1 ml 60%. After centrifugation at 
100,000 gav (18 h at 4°C) in a rotor (SW41 Ti; Beckman Coulter), 20 × 
0.6 ml fractions were collected from the top. PM and ER membranes peaked 
in fractions 7–9 and 17 and18, respectively. Equal amounts of protein from 
the PNS, the crude mitochondrial membrane pellet, and the collected PM 
and ER membrane peaks were subjected to immunoblot analysis. This re-
vealed that the collected ER membranes were virtually devoid of other 
organelles except for a minor contamination with PM (<10%).
Microscopy and image analysis
Cells were fixed in 4% paraformaldehyde/PBS, processed for immuno-
fluorescence as described previously for S2 (Kondylis and Rabouille, 2003) 
and HeLa cells (Tafesse et al., 2007), and mounted in Vectashield medium 
containing DAPI (Vector Laboratories). Images were captured at RT using a 
confocal microscope (LSM 510 Meta; Carl Zeiss, Inc.) with a 63× 1.40 
NA Plan Apo oil objective (Carl Zeiss, Inc.) or with a confocal microscope 
(D-eclipse C1; Nikon) with 60× 1.40 NA Plan Apo oil objective (Nikon). 
The fluorochromes used were DAPI, ex = 360 nm and em= 460 nm; FITC/
Alexa Fluor 488, ex = 488 nm and em = 515 nm; Texas red/Alexa Fluor 
568, ex = 568 nm and em = 585 nm. Projections were obtained by col-
lecting series of 0.4-µm sections that were acquired and combined using 
LSM software (Carl Zeiss, Inc.) or EZ-C1 software (Nikon). Images were 
further processed using Photoshop software (version 7.0.1; Adobe).
The tER–Golgi fragmentation phenotype in S2 cells was assessed as 
described previously in Kondylis and Rabouille (2003). In brief, all cells 
from each projection were assigned to either one of two categories: cells 
with a wild-type Golgi morphology, which corresponds to 17–25 large, 
dGMAP, or d120kd-labeled spots, and cells with a fragmented Golgi mor-
phology, corresponding to numerous smaller labeled spots. Results were 
expressed as a percentage of cells displaying a fragmented Golgi mor-
phology. The averages were derived from three independent experiments, 
each analyzing at least 400 (or ≥75 transfected) cells per condition. The 
statistical significance of all data obtained was assessed by two-tailed un-
paired  Student’s  t  tests.  P  ≤  0.001  was  considered  significant  and  is 
marked by an asterisk, whereas P > 0.001 is indicated (Fig. 7, C and D).
S2 cells were fixed and processed for immunoelectron microscopy 
as described previously in Kondylis and Rabouille (2003). Ultrathin cryo-
sections were examined using an electron microscope (1200 EX; JEOL). 
All antibodies used for immunolabeling are described in Online supple-
mental material.
Delta and VSV-045G transport assays
The Delta transport assay was performed using the cell line Delta-WTNd-
eMYC as described previously in Kondylis and Rabouille (2003). In brief, 
S2 cells were treated with different dsRNA for the indicated time. The 
Delta protein was induced for 1 h with 1 mM CuSO4 and chased in the 
absence  of  CuSO4  for  different  time  points.  Subsequently,  cells  were 
fixed, immunostained, and Delta arrival at PM was monitored by immuno-
fluorescence microscopy. For VSV-045G transport assay, HeLa cells were 
treated with different siRNA constructs for 7 d, transfected with VSV-
045G-GFP, kept at 39.5°C for 16 h, and chased at 32°C for different 
time points as indicated.
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Fig. S1 shows the effect of externally added phospholipid on CPE produc-
tion levels in lysates of normal and hSMSr-overexpressing HeLa cells. Fig. 
S2 shows that loss of the SAM domain causes a redistribution of SMSr from 
the ER to the Golgi. Fig. S3 shows that SMSr-depleted cells accumulate all 
major species of ceramide but no sphingosine. Fig. S4 shows the single chan-
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